Rising Costs of Type 2 Diabetes Treatment in Vietnam: A 2018-2022 Overview

Type 2 diabetes mellitus (T2DM) is a chronic condition that significantly impacts metabolic health and healthcare systems globally. In Vietnam, the prevalence of T2DM is on the rise, leading to increased healthcare expenditures that strain resources. This study provides a comprehensive analysis of treatment costs for T2DM across various hospital tiers from 2018 to 2022, using retrospective health insurance data to highlight the financial burden of this chronic disease. The findings reveal a substantial increase in total treatment expenditures from $227.17 million in 2018 to $425.53 million in 2022. Notably, the majority of spending occurred in Class I and Class II healthcare facilities, although their share of total costs decreased over time. In contrast, expenditures in unclassified and special-class facilities rose, indicating a shift in where diabetes care is being administered. Medications accounted for the largest portion of these costs, ranging from 49.65% to 78.95%, followed by laboratory tests, which constituted 7.31% to 19.89% of total expenditures across all hospital classifications. These findings underscore the importance of addressing the rising costs associated with T2DM treatment. For individuals managing diabetes, understanding the financial implications of their treatment can inform choices about medication adherence and healthcare utilization. Additionally, the study suggests that enhancing diabetes screening and follow-up care at lower-level healthcare facilities could alleviate pressure on higher-tier hospitals, ultimately improving patient outcomes and resource allocation. In relation to metabolic health, this study connects to several key biomarkers. Monitoring fasting glucose and insulin levels can provide insights into an individual's risk of developing T2DM. Furthermore, understanding lipid profiles, including triglycerides and HDL levels, is crucial for assessing cardiovascular risk in diabetic patients. Utilizing tools like the HOMA-IR calculator can help individuals gauge their insulin resistance, a critical factor in managing diabetes effectively. In conclusion, the rising costs of T2DM treatment in Vietnam highlight an urgent need for improved healthcare strategies. Individuals should be proactive in managing their metabolic health by monitoring relevant biomarkers and seeking comprehensive care that includes regular screenings and lifestyle interventions. By doing so, they can not only reduce their personal healthcare costs but also contribute to a more sustainable healthcare system overall.